Financhill
Back

John Hancock Multifactor Mid Cap ETF Vs. Celldex Therapeutics, Inc. Industry Stock Comparison

Sell
40

JHMM
John Hancock Multifactor Mid Cap ETF

Last Price:
$67.62
Seasonality Move:
3.56%
Sell
48

CLDX
Celldex Therapeutics, Inc.

Last Price:
$31.05
Seasonality Move:
20.93%
Sell
40
John Hancock Multifactor Mid Cap ETF (JHMM) is a Sell

Is John Hancock Multifactor Mid Cap ETF a Buy, Sell or Hold?

  • The current John Hancock Multifactor Mid Cap ETF [JHMM] share price is $67.73. The Score for JHMM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • JHMM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Celldex Therapeutics, Inc. (CLDX) is a Sell

Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JHMM Stock Price Chart

What is John Hancock Multifactor Mid Cap ETF's stock price today?

CLDX Stock Price Chart

What is Celldex Therapeutics, Inc.'s stock price today?

  • The Celldex Therapeutics, Inc. share price today is $31.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

JHMM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 50.18 Buy
Chaikin Money Flow: 150561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.24 - 69.3) Sell
Bollinger Bands (100): (65.25 - 69.69) Buy

CLDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 55.97 Buy
Chaikin Money Flow: 3988094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.43 - 31.31) Buy
Bollinger Bands (100): (24.48 - 29.54) Buy

JHMM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.89 Buy
20-day SMA: 67.12 Buy
50-day SMA: 68.89 Sell
200-day SMA: 65.38 Buy
8-day EMA: 67.02 Buy
20-day EMA: 67.43 Buy
50-day EMA: 67.99 Sell
200-day EMA: 65.56 Buy

CLDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.05 Buy
20-day SMA: 30.57 Buy
50-day SMA: 27.66 Buy
200-day SMA: 25.4 Buy
8-day EMA: 30.94 Buy
20-day EMA: 30.26 Buy
50-day EMA: 28.67 Buy
200-day EMA: 26.26 Buy

John Hancock Multifactor Mid Cap ETF Earnings Growth & JHMM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.

John Hancock Multifactor Mid Cap ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Celldex Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):